Stock Details
BAYZF is Bayer Aktiengesellschaft's stock. Stock exchange Other OTC (Currency USD). Average price in 50 days is 56.19$. Average daily volumn in 3 months 8.16k. Market cap 60.16B



Stock symbol : BAYZF. Exchange : Other OTC. Currency : USD
Lastest price : 61.24$. Total volume : 2.46k. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Bayer Aktiengesellschaft (BAYZF)
Last Price
61.24$
Change
0.19
Volume
2.46k

Previous Close61.05
Open61.28
Day Range61.17-61.28
Bid0.00 x N/A
Ask0.00 x N/A
Volume2.46k
Average Volume8.16k
Market Cap60.16B
Beta1.12
52 Week Range45.99-74.34
Trailing P/E11.75
Foward P/EN/A
Dividend (Yield %)3.44%
Ex-Dividend Date2022-05-02



Financial Details



Organization

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescr... iption over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Market Cap:
60.16B
Revenue:
44.08B
Total Assets:
120.24B
Total Cash:
4.56B


News about "Bayer Aktiengesellschaft"

bayer-investor-calls-for-swift-replacement-of-ceo-newspaper-image

Bayer investor calls for swift replacement of CEO -newspaper

Source from : Reuters on MSN - 23 hours ago

Bayer investor Deka has called for CEO Werner Baumann to be replaced ahead of his scheduled departure, adding to mounting pressure on the German drugmaker.See details»


Bayer Sued for Barring Non-U.S. Citizen From Roundup Settlement

Source from : U.S. News & World Report - 9 days ago

A new U.S. lawsuit on Thursday accused Germany's Bayer AG of illegally excluding a Virginia farmworker from a settlement over claims its Roundup weedkiller causes cancer, because she is not a U.S ...See details»


Inclusive Capital takes a stake in Bayer โ€” 3 ways it may build value with a sustainable focus

Source from : CNBC - 7 days ago

Business: Bayer AG is a 55-billion euro German multinational pharmaceutical and biotechnology company. It operates through three segments: (i) Pharmaceuticals (roughly 6 billion euros of EBITDA ...See details»


Bayer investor criticizes company chair for lack of initiative

Source from : Reuters - 6 days ago

A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Ratta/File Photo FRANKFURT, Jan 22 (Reuters ...See details»


Bayer Aktiengesellschaft (BAYN.DE)

Source from : Yahoo Finanzen - 9 days ago

Bayer strebt fรผr sein Medikament Kerendia zur Behandlung von Patienten mit chronischer Nierenerkrankung und Typ-2-Diabetes eine Zulassungserweiterung in der EU an. Finerenon, das unter dem Markennamen ...See details»


Bayer shifts pharma focus away from โ€˜innovation unfriendlyโ€™ Europe

Source from : The Financial Times - 12 days ago

Weโ€™ll send you a myFT Daily Digest email rounding up the latest Bayer AG news every morning. Bayer has said it is shifting the focus of its pharmaceutical business to the US and away from Europe ...See details»


Activist Bluebell Said to Build Bayer Stake in Breakup Push

Source from : MSN - 18 days ago

(Bloomberg) -- Bayer AG shares climbed after people with knowledge of the matter said activist investor Bluebell Capital Partners has built a stake in the company and is pushing for a breakup.See details»


Bayer AG ADR

Source from : Wall Street Journal - 2 years ago

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...See details»


Bayer Acquires Imaging AI Developer Blackford

Source from : MarketWatch - 11 days ago

By Giulia Petroni Bayer AG said Wednesday that it has agreed to acquire the British developer of artificial intelligence imaging software Blackford ...See details»


Activist Bluebell builds stake in Bayer, pushes for company breakup -Bloomberg

Source from : Euronews - 17 days ago

Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday ...See details»


Bayer AG to use Google Cloudโ€™s Tensorflow Processing Units

Source from : infotechlead - 15 days ago

Bayer AG has selected Google Cloud to drive early drug discovery that will apply Google Cloudโ€™s Tensorflow Processing Units (TPUs). Increasing R&D efficiency to accelerate development of ...See details»


Bayer AG PK (BAYRY)

Source from : Investing - 8 days ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»


Bayer to Accelerate Drug Discovery with Google Cloud's High-Performance Compute Power

Source from : Yahoo - 17 days ago

Jan. 11, 2023 /PRNewswire/ -- Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensorflow Processing Units (TPUs), which are ...See details»


Investors in Bayer (ETR:BAYN) have unfortunately lost 42% over the last five years

Source from : Yahoo Finance - 23 days ago

But even the best stock picker will only win with some selections. So we wouldn't blame long term Bayer Aktiengesellschaft (ETR:BAYN) shareholders for doubting their decision to hold, with the stock ...See details»